Variants in MED12L, encoding a subunit of the mediator kinase module, are responsible for intellectual disability associated with transcriptional defect

  • A Correction to this article was published on 03 July 2019



Mediator is a multiprotein complex that allows the transfer of genetic information from DNA binding proteins to the RNA polymerase II during transcription initiation. MED12L is a subunit of the kinase module, which is one of the four subcomplexes of the mediator complex. Other subunits of the kinase module have been already implicated in intellectual disability, namely MED12, MED13L, MED13, and CDK19.


We describe an international cohort of seven affected individuals harboring variants involving MED12L identified by array CGH, exome or genome sequencing.


All affected individuals presented with intellectual disability and/or developmental delay, including speech impairment. Other features included autism spectrum disorder, aggressive behavior, corpus callosum abnormality, and mild facial morphological features. Three individuals had a MED12L deletion or duplication. The other four individuals harbored single-nucleotide variants (one nonsense, one frameshift, and two splicing variants). Functional analysis confirmed a moderate and significant alteration of RNA synthesis in two individuals.


Overall data suggest that MED12L haploinsufficiency is responsible for intellectual disability and transcriptional defect. Our findings confirm that the integrity of this kinase module is a critical factor for neurological development.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3

Change history

  • 03 July 2019

    In the Acknowledgements section of the paper the authors neglected to mention that the study was supported by a grant from the National Human Genome Research Institute (NHGRI) UM1HG007301 (SMH, MLT). In addition, the award of MD was associated with the authors Michelle Thompson and Susan Hiatt instead of PhD. The PDF and HTML versions of the Article have been modified accordingly.


  1. 1.

    Kornberg RD. Mediator and the mechanism of transcriptional activation. Trends Biochem Sci. 2005;30:235–239.

  2. 2.

    Conaway RC, Conaway JW. Origins and activity of the Mediator complex. Semin Cell Dev Biol. 2011;22:729–734.

  3. 3.

    Allen BL, Taatjes DJ. The Mediator complex: a central integrator of transcription. Nat Rev Mol Cell Biol. 2015;16:155–166.

  4. 4.

    Berk AJ. Yin and yang of mediator function revealed by human mutants. Proc Natl Acad Sci USA 2012;109:19519–19520.

  5. 5.

    Jeronimo C, Robert F. The Mediator complex: at the nexus of RNA polymerase II transcription. Trends Cell Biol. 2017;27:765–783.

  6. 6.

    Risheg H, Graham JM, Clark RD, et al. A recurrent mutation in MED12 leading to R961W causes Opitz–Kaveggia syndrome. Nat Genet. 2007;39:451–453.

  7. 7.

    Rump P, Niessen RC, Verbruggen KT, et al. A novel mutation in MED12 causes FG syndrome (Opitz–Kaveggia syndrome). Clin Genet. 2011;79:183–188.

  8. 8.

    Graham JM, Schwartz CE. MED12 related disorders. Am J Med Genet A. 2013;161A:2734–2740.

  9. 9.

    Schwartz CE, Tarpey PS, Lubs HA, et al. The original Lujan syndrome family has a novel missense mutation (p.N1007S) in the MED12 gene. J Med Genet. 2007;44:472–477.

  10. 10.

    Vulto-van Silfhout AT, de Vries BBA, van Bon BWM, et al. Mutations in MED12 cause X-linked Ohdo syndrome. Am J Hum Genet. 2013;92:401–406.

  11. 11.

    Isidor B, Lefebvre T, Le Vaillant C, et al. Blepharophimosis, short humeri, developmental delay and Hirschsprung disease: expanding the phenotypic spectrum of MED12 mutations. Am J Med Genet A. 2014;164A:1821–1825.

  12. 12.

    Donnio L-M, Bidon B, Hashimoto S, et al. MED12-related XLID disorders are dose-dependent of immediate early genes (IEGs) expression. Hum Mol Genet. 2017;26:2062–2075.

  13. 13.

    Mukhopadhyay A, Kramer JM, Merkx G, et al. CDK19 is disrupted in a female patient with bilateral congenital retinal folds, microcephaly and mild mental retardation. Hum Genet. 2010;128:281–291.

  14. 14.

    Smol T, Petit F, Piton A, et al. MED13L-related intellectual disability: involvement of missense variants and delineation of the phenotype. Neurogenetics. 2018;19:93–103.

  15. 15.

    Snijders Blok L, Hiatt SM, Bowling KM, et al. De novo mutations in MED13, a component of the Mediator complex, are associated with a novel neurodevelopmental disorder. Hum Genet. 2018;13:675–685.

  16. 16.

    Firth HV, Richards SM, Bevan AP, et al. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet. 2009;84:524–533.

  17. 17.

    Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat. 2015;36:928–930.

  18. 18.

    Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y, Ward P, Braxton A, Wang M, Buhay C, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 2014;312: 1870–1879.

  19. 19.

    Bowling KM, Thompson ML, Amaral MD, Finnila CR, Hiatt SM, Engel KL, Cochran JN, Brothers KB, East KM, Gray DE, et al. Genomic diagnosis for children with intellectual disability and/or developmental delay. Genome Med. 2017;9:43.

  20. 20.

    Calmels N, Greff G, Obringer C, Kempf N, Gasnier C, Tarabeux J, Miguet M, Baujat G, Bessis D, Bretones P, et al. Uncommon nucleotide excision repair phenotypes revealed by targeted high-throughput sequencing. Orphanet J Rare Dis. 2016;11:26.

  21. 21.

    Limsirichaikul S, Niimi A, Fawcett H, Lehmann A, Yamashita S, Ogi T. A rapid nonradioactive technique for measurement of repair synthesis in primary human fibroblasts by incorporation of ethynyl deoxyuridine (EdU). Nucleic Acids Res. 2009;37:e31.

  22. 22.

    Epanchintsev A, Costanzo F, Rauschendorf M-A, Caputo M, Ye T, Donnio L-M, Proietti-de-Santis L, Coin F, Laugel V, Egly J-M. Cockayne’s syndrome A and B proteins regulate transcription arrest after genotoxic stress by promoting ATF3 degradation. Mol Cell. 2017;68:1054–.e6.

  23. 23.

    Olsen L, Sparsø T, Weinsheimer SM, Dos Santos MBQ, Mazin W, Rosengren A, Sanchez XC, Hoeffding LK, Schmock H, Baekvad-Hansen M, et al. Prevalence of rearrangements in the 22q11.2 region and population-based risk of neuropsychiatric and developmental disorders in a Danish population: a case-cohort study. Lancet Psychiatry. 2018;5:573–580.

  24. 24.

    Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O’Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–291.

  25. 25.

    Cai D-C, Fonteijn H, Guadalupe T, Zwiers M, Wittfeld K, Teumer A, Hoogman M, Arias-Vásquez A, Yang Y, Buitelaar J, et al. A genome-wide search for quantitative trait loci affecting the cortical surface area and thickness of Heschl’s gyrus. Genes Brain Behav. 2014;13:675–685.

  26. 26.

    Wan C, Borgeson B, Phanse S, Tu F, Drew K, Clark G, Xiong X, Kagan O, Kwan J, Bezginov A, et al. Panorama of ancient metazoan macromolecular complexes. Nature. 2015;525:339–344.

  27. 27.

    Martin C-A, Murray JE, Carroll P, Leitch A, Mackenzie KJ, Halachev M, Fetit AE, Keith C, Bicknell LS, Fluteau A, et al. Mutations in genes encoding condensin complex proteins cause microcephaly through decatenation failure at mitosis. Genes Dev. 2016;30:2158–2172.

  28. 28.

    Clark AD, Oldenbroek M, Boyer TG. Mediator kinase module and human tumorigenesis. Crit Rev Biochem Mol Biol. 2015;50:393–426.

  29. 29.

    Jeronimo C, Langelier M-F, Bataille AR, Pascal JM, Pugh BF, Robert F. Tail and kinase modules differently regulate core Mediator recruitment and function in vivo. Mol Cell. 2016;64:455–466.

  30. 30.

    Huang Y, Li W, Yao X, Lin Q-J, Yin J-W, Liang Y, Heiner M, Tian B, Hui J, Wang G. Mediator complex regulates alternative mRNA processing via the MED23 subunit. Mol Cell. 2012;45:459–469.

  31. 31.

    Lai F, Orom UA, Cesaroni M, Beringer M, Taatjes DJ, Blobel GA, Shiekhattar R. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature. 2013;494:497–501.

  32. 32.

    Graham JM, Visootsak J, Dykens E, Huddleston L, Clark RD, Jones KL, Moeschler JB, Opitz JM, Morford J, Simensen R, et al. Behavior of 10 patients with FG syndrome (Opitz–Kaveggia syndrome) and the p.R961W mutation in the MED12 gene. Am J Med Genet A. 2008;146A:3011–3017.

  33. 33.

    Muncke N, Jung C, Rüdiger H, Ulmer H, Roeth R, Hubert A, Goldmuntz E, Driscoll D, Goodship J, Schön K, et al. Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries). Circulation. 2003;108:2843–2850.

  34. 34.

    Asadollahi R, Oneda B, Sheth F, Azzarello-Burri S, Baldinger R, Joset P, Latal B, Knirsch W, Desai S, Baumer A, et al. Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability. Eur J Hum Genet. 2013;21:1100–1104.

  35. 35.

    Adegbola A, Musante L, Callewaert B, Maciel P, Hu H, Isidor B, Picker-Minh S, Le Caignec C, Delle Chiaie B, Vanakker O, et al. Redefining the MED13L syndrome. Eur J Hum Genet. 2015;23:1308–1317.

  36. 36.

    Kristensen U, Epanchintsev A, Rauschendorf M-A, Laugel V, Stevnsner T, Bohr VA, Coin F, Egly J-M. Regulatory interplay of Cockayne syndrome B ATPase and stress-response gene ATF3 following genotoxic stress. Proc Natl Acad Sci USA 2013;110:E2261–2270.

  37. 37.

    Wang Y, Chakravarty P, Ranes M, Kelly G, Brooks PJ, Neilan E, Stewart A, Schiavo G, Svejstrup JQ. Dysregulation of gene expression as a cause of Cockayne syndrome neurological disease. Proc Natl Acad Sci USA. 2014;111:14454–14459.

  38. 38.

    Compe E, Malerba M, Soler L, Marescaux J, Borrelli E, Egly J-M. Neurological defects in trichothiodystrophy reveal a coactivator function of TFIIH. Nat Neurosci. 2007;10:1414–1422.

  39. 39.

    Kuschal C, Botta E, Orioli D, Digiovanna JJ, Seneca S, Keymolen K, Tamura D, Heller E, Khan SG, Caligiuri G, et al. GTF2E2 mutations destabilize the general transcription factor complex TFIIE in individuals with DNA repair-proficient trichothiodystrophy. Am J Hum Genet. 2016;98:627–642.

Download references


We thank the patients and their families for participating in this study. The study was supported by a grant from the National Human Genome Research Institute (NHGRI) UM1HG007301 (SMH, MLT).

Author information

Correspondence to Mathilde Nizon MD.

Ethics declarations


The Department of Molecular and Human Genetics at Baylor College of Medicine receives revenue from clinical genetic testing conducted at Baylor Genetics. M.T.C. and K.M. are employees of GeneDx, Inc., a wholly owned subsidiary of OPKO Health, Inc. The other authors declare no conflicts of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nizon, M., Laugel, V., Flanigan, K.M. et al. Variants in MED12L, encoding a subunit of the mediator kinase module, are responsible for intellectual disability associated with transcriptional defect. Genet Med 21, 2713–2722 (2019).

Download citation


  • MED12L
  • intellectual disability
  • mediator complex
  • transcriptional defect
  • corpus callosum

Further reading